• 

  ICMR to examine effectiveness of AstraZeneca's SII-produced Covishield and Bharat Biotech's Covaxin

  India | May 26, 2021 21:49 IST

  Around 4K people above the age of 45 yrs who have taken either one or both doses of any of these two vaccines will be reviewed, according to Dr Tarun Bhatnagar, senior scientist at ICMR's NIE in Chennai.

• 

  Black fungus: ICMR releases guidelines for mucormycosis

  News | May 21, 2021 14:40 IST

  According to doctors, cases of mucormycosis are being seen among Covid patients who were administered steroids to treat symptoms, and particularly among those who are suffering from diabetes and cancer.

• 

  ICMR approves Mylab's self-use kit CoviSelf

  Aaj Ki Baat | May 20, 2021 22:40 IST

  At a time when more and more testings are being done to trace, treat Covid cases in the country, the Indian Council of Medical Research (ICMR) on Thursday approved a home-based rapid antigen testing (RAT) kit — CoviSelf, for Covid-19.

• 

  CoviSelf: How to use self-testing Covid kit | Watch

  News | May 20, 2021 16:24 IST

  The Indian Council of Medical Research (ICMR), the country's apex health research body, has approved a home-based rapid antigen testing (RAT) kit -- CoviSelf, for Covid-19. It said that the kit should be used only on symptomatic individuals and on immediate contacts of laboratory confirmed positive cases. It will provide results in 15 minutes.

• 

  CoviSelf: How to use self-testing Covid kit, step-by-step guide

  India | May 20, 2021 22:28 IST

  How to use CoviSelf: The ICMR has approved a home-based rapid antigen testing (RAT) kit. The kit should be used only on symptomatic individuals.

• 

  Covid home testing kit approved; ICMR advises against indiscriminate use

  India | May 20, 2021 8:26 IST

  The Indian Council of Medical Research (ICMR) on Wednesday released an advisory for COVID-19 home testing using Rapid Antigen Tests (RAT).

• 

  Plasma Therapy Dropped As Treatment For COVID-19

  News | May 18, 2021 12:40 IST

  The government on Monday removed convalescent plasma therapy from the country's clinical management guidelines on Covid-19. The move comes as the therapy was found to be ineffective in reducing the progression to severe disease or death.

• 

  Youth getting slightly more affected in COVID second wave as they might have begun going out: ICMR

  India | May 11, 2021 23:59 IST

  The second wave of the COVID-19 pandemic is impacting slightly more number of younger people as they might have begun going out and also because of some variants of SARs-COV-2 prevalent in the country, the ICMR chief said on Tuesday.

• 

  India conducting 18-20 lakh COVID tests a day: ICMR

  India | May 11, 2021 20:26 IST

  At a press conference, ICMR director general Dr Balram Bhargava said that the national COVID-19 positivity rate is around 21 per cent and about 42 per cent (310/734) of the districts are reporting a positivity rate more than the national average.

• 

  Why insist on RTPCR test report to approve requisition for Remdesivir: HC asks Delhi govt, ICMR

  India | May 05, 2021 23:41 IST

  A bench of Justices Vipin Sanghi and Rekha Palli said that the court had earlier also taken note that on several occasions RTPCR tests have given false-negative results and therefore, it cannot be insisted upon to provide treatment or medication to patients when they otherwise exhibit symptoms of COVID-19 infection.

• 

  Do away with RT-PCR test for inter-state travel for healthy individuals to reduce load on labs: ICM

  India | May 04, 2021 23:33 IST

  The advisory stated that RT-PCR test must not be repeated in any individual who has tested positive once either by RAT or RT-PCR and that testing is not required for COVID-19 recovered individuals at the time of hospital discharge in accordance with the discharge policy of the Ministry of Health.

Advertisement
• 

  ICMR grants permission for drone trial to deliver vaccine

  India | April 23, 2021 12:58 IST

  The Indian Council of Medical Research (ICMR) has granted permission for conducting a feasibility study of Covid-19 vaccine delivery using drones in collaboration with IIT Kanpur.

• 

  COVID-19: Government permits ICMR to conduct study on using drones to deliver vaccine

  India | April 22, 2021 21:59 IST

  ICMR will conduct this study in collaboration with Indian Institute of Technology Kanpur, the ministry's press release said.

• 

  When will second Covid wave come down? Top expert explains

  News | April 13, 2021 21:08 IST

  NK Arora, Operations Research Group Head, ICMR, explains when will the second Covid wave in India come down.

• 

  With 39,726 new infections, India reports highest COVID-19 cases

  News | March 19, 2021 12:23 IST

  India reported highest coronavirus cases of 2021 on March 19.

• 

  COVID-19: India records over 87 lakh vaccination

  News | February 16, 2021 14:24 IST

  As per the data released by Ministry of Health and Family Welfare (MoHFW), India on February 16 reported single-day spike of 9,121 new coronavirus cases in the last 24 hours.

• 

  Over 82 lakh beneficiaries vaccinated against COVID

  News | February 15, 2021 12:26 IST

  As per the data released by Ministry of Health and Family Welfare (MoHFW), India on February 15 reported single-day spike of 11,649 new coronavirus cases in the last 24 hours.

• 

  COVID-19: Nearly 80 lakh get vaccine jab in India

  News | February 13, 2021 12:19 IST

  Total of 79,67,647 beneficiaries have been vaccinated for COVID-19 across India .

• 

  COVID-19: Over 49 lakh vaccination registered in India

  News | February 05, 2021 11:50 IST

  As per the data released by Ministry of Health and Family Welfare (MoHFW), India on February 05 reported single-day spike of 12,408 new coronavirus cases in the last 24 hours.

• 

  21.5% of India's population showed evidence of past exposure to COVID: ICMR survey

  India | February 05, 2021 10:06 IST

  Over 21 per cent of the population, aged 10 years and above, showed evidence of past exposure to COVID-19 in the ICMR's latest national serosurvey, the government said on Thursday, noting that a large proportion of people are still vulnerable to the infection.